Investor Presentaiton slide image

Investor Presentaiton

Appendix 1. Novo Nordisk at a glance 2. Diabetes and obesity 3. Biopharmaceuticals 4. Financials 5. Sustainability changing diabetes® Investor presentation First three months of 2017 Slide 21 novo nordisk
View entire presentation